1d
Investor's Business Daily on MSNBiotech Stocks Take A Tariffs Hit. Pharmaceuticals Are Exempt — For Now.Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...
Wall Street was headed for heavy losses and the dollar slumped on Thursday, as investors bet that Donald Trump’s sweeping ...
StockStory.org on MSN1d
Supernus Pharmaceuticals (SUPN): Buy, Sell, or Hold Post Q4 Earnings?Supernus Pharmaceuticals has been treading water for the past six months, recording a small loss of 1.6% while holding steady at $31.52. However, the stock is beating the S&P 500’s 7% decline during ...
Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to ...
Rigel Pharmaceuticals is now reporting net income and has three marketed drugs, all of which can continue to grow. Read more ...
Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...
Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...
Analysts' ratings for Alnylam Pharmaceuticals ALNY over the last quarter vary from bullish to bearish, as provided by 27 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results